AnaptysBio Inc (ANAB)
25.04
+1.09
(+4.55%)
USD |
NASDAQ |
May 22, 16:00
24.97
-0.07
(-0.28%)
After-Hours: 20:00
AnaptysBio Price to Book Value: 14.32 for May 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 22, 2024 | 14.32 |
| May 21, 2024 | 13.69 |
| May 20, 2024 | 14.30 |
| May 17, 2024 | 14.33 |
| May 16, 2024 | 14.56 |
| May 15, 2024 | 14.64 |
| May 14, 2024 | 14.44 |
| May 13, 2024 | 13.72 |
| May 10, 2024 | 13.39 |
| May 09, 2024 | 15.00 |
| May 08, 2024 | 14.72 |
| May 07, 2024 | 14.68 |
| May 06, 2024 | 14.73 |
| May 03, 2024 | 15.20 |
| May 02, 2024 | 15.06 |
| May 01, 2024 | 14.88 |
| April 30, 2024 | 13.92 |
| April 29, 2024 | 12.18 |
| April 26, 2024 | 12.01 |
| April 25, 2024 | 10.79 |
| April 24, 2024 | 11.02 |
| April 23, 2024 | 10.97 |
| April 22, 2024 | 11.24 |
| April 19, 2024 | 11.36 |
| April 18, 2024 | 11.34 |
| Date | Value |
|---|---|
| April 17, 2024 | 12.28 |
| April 16, 2024 | 12.20 |
| April 15, 2024 | 12.16 |
| April 12, 2024 | 12.98 |
| April 11, 2024 | 14.14 |
| April 10, 2024 | 12.68 |
| April 09, 2024 | 12.31 |
| April 08, 2024 | 11.82 |
| April 05, 2024 | 12.05 |
| April 04, 2024 | 12.18 |
| April 03, 2024 | 11.85 |
| April 02, 2024 | 11.92 |
| April 01, 2024 | 12.19 |
| March 31, 2024 | |
| March 28, 2024 | 6.841 |
| March 27, 2024 | 6.495 |
| March 26, 2024 | 6.561 |
| March 25, 2024 | 6.410 |
| March 22, 2024 | 6.583 |
| March 21, 2024 | 7.427 |
| March 20, 2024 | 7.272 |
| March 19, 2024 | 7.069 |
| March 18, 2024 | 7.038 |
| March 15, 2024 | 7.123 |
| March 14, 2024 | 7.169 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6563
Minimum
Nov 08 2019
15.20
Maximum
May 03 2024
2.792
Average
2.253
Median
Sep 30 2019
Price to Book Value Benchmarks
| XOMA Corp | 3.564 |
| Fate Therapeutics Inc | 0.9751 |
| Ocular Therapeutix Inc | 2.278 |
| Apellis Pharmaceuticals Inc | 19.84 |
| Sutro Biopharma Inc | 3.555 |
Price to Book Value Related Metrics
| PS Ratio | 29.05 |
| PEG Ratio | -0.1518 |
| Price | 25.04 |
| Earnings Yield | -24.52% |
| Market Cap | 684.06M |
| PEGY Ratio | -0.1518 |